// App-Quantinova.ai

724 : Time to first-line chemotherapy and travel distance to the cancer center and their relationship to subsequent-line therapies in stage IV CRC.

Researchers

Presenter

  • Mahjabeen Fatima Iqbal

Principal Investigators

  • Aleksi Emil Suo

  • Neha Papneja

  • Nayyer Iqbal

  • Tahir Abbas

  • Kamal Haider

  • Adnan Zaidi

  • Shahid Ahmed

Medical Centers

  • Kings College London, London, United Kingdom

  • University of Saskatchewan, Saskatoon, SK, Canada

  • Department of Surgery, University of Saskatchewan, Saskatoon, SK, Canada

  • Saskatchewan Cancer Agency, Saskatoon, Saskatchewan, Canada

  • Saskatoon Cancer Centre, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK, Canada

  • Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK, Canada

  • Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK, Canada

  • Department of Medical Oncology, Saskatoon Cancer Centre, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK, Canada

Locations

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved